TickerFacts.

A business in context

CNSY research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-352444

  2. 8-K · Current report

    Report date 2026-08-14 · 0001193125-26-352346 · Items 2.02,9.01

  3. 8-K · Current report

    Report date 2026-08-03 · 0001193125-26-332939 · Items 5.03,9.01

  4. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292654

  5. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292649

  6. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292648

  7. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292644

  8. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292643

  9. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292642

  10. 4 · Ownership change

    Report date 2026-07-01 · 0001193125-26-292639

  11. 8-K · Current report

    Report date 2026-06-01 · 0001193125-26-259703 · Items 1.01,9.01

  12. 4 · Ownership change

    Report date 2026-05-14 · 0001193125-26-228933

  13. 8-K · Current report

    Report date 2026-05-14 · 0001193125-26-227059 · Items 5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-226978

  15. 8-K · Current report

    Report date 2026-05-15 · 0001193125-26-226747 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-20 · 0001193125-26-165205 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-04-08 · 0001193125-26-148920 · Items 5.02,9.01

  18. 8-K · Current report

    Report date 2026-04-08 · 0001193125-26-146335 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-01 · 0001193125-26-140267 · Items 3.03,5.03,8.01,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-05-14 · 0001193125-26-134646

  21. 8-K · Current report

    Report date 2026-03-20 · 0001193125-26-125195 · Items 5.02

  22. 8-K · Current report

    Report date 2026-03-11 · 0001193125-26-104291 · Items 5.08,8.01

  23. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-104258

  24. 8-K · Current report

    Report date 2026-03-12 · 0001193125-26-104218 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-02-09 · 0001193125-26-051379 · Items 5.02

  26. 8-K · Current report

    Report date 2026-01-22 · 0001193125-26-018675 · Items 8.01,9.01

  27. 8-K · Current report

    Report date 2026-01-13 · 0001193125-26-015346 · Items 1.01,8.01,9.01

  28. 8-K · Current report

    Report date 2025-11-17 · 0001193125-25-283935 · Items 7.01,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-258596

  30. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-258568 · Items 2.02,9.01

  31. 8-K · Current report

    Report date 2025-10-16 · 0001193125-25-244275 · Items 1.01,2.03,9.01

  32. 8-K · Current report

    Report date 2025-08-26 · 0001193125-25-188075 · Items 8.01

  33. 8-K · Current report

    Report date 2025-08-14 · 0001193125-25-180814 · Items 8.01,9.01

  34. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-108874

  35. 8-K · Current report

    Report date 2025-08-14 · 0000950170-25-108854 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2025-08-13 · 0001193125-25-179382 · Items 8.01

  37. 8-K · Current report

    Report date 2025-08-07 · 0001193125-25-179012 · Items 5.07

  38. DEF 14A · Proxy statement

    Report date 2025-08-07 · 0001140361-25-026611

  39. 8-K · Current report

    Report date 2025-07-16 · 0001193125-25-161239 · Items 4.01,9.01

  40. 8-K · Current report

    Report date 2025-06-17 · 0001193125-25-143665 · Items 1.01,3.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 17 transaction rows17AExercise / conversion: 8 transaction rows8MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

25 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-14
2026-05-18
van Es-Johansson AnA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3686.00.0
2026-05-14
2026-05-18
van Es-Johansson AnA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3686.00.0
2026-05-14
2026-05-18
Hawkins Richard JA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3686.00.0
2026-05-14
2026-05-18
Hawkins Richard JA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3686.00.0
2026-05-14
2026-05-18
Guse KyleA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3686.00.0
2026-05-14
2026-05-18
Guse KyleA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3686.00.0
2026-05-14
2026-05-18
Clowes HowardA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3686.00.0
2026-05-14
2026-05-18
Clowes HowardA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3686.00.0
2026-05-14
2026-05-18
ANDREWS RONALD ASBURYA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3686.00.0
2026-05-14
2026-05-18
ANDREWS RONALD ASBURYA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
1600.00.0
2026-05-14
2026-05-18
ANDREWS RONALD ASBURYA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3686.00.0
2026-05-14
2026-05-18
Sims Andrew John Hugh MacIntyreA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
3443.00.0
2026-05-14
2026-05-18
Sims Andrew John Hugh MacIntyreA · Grant / award
Acquired
Restricted Stock Units
Derivative security
3443.00.0
2026-05-14
2026-05-18
HEDRICK MARC HA · Grant / award
Acquired
Restricted Stock Units
Derivative security
23834.00.0
2026-05-14
2026-05-18
HEDRICK MARC HA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
23834.00.0
2026-04-20
2026-04-22
Daniels Eric JosephA · Grant / award
Acquired
Restricted Stock Units
Derivative security
20000.00.0
2026-04-20
2026-04-22
Daniels Eric JosephA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
20000.00.0
2026-04-01
2026-04-01
Sims Andrew John Hugh MacIntyreM · Exercise / conversion
Acquired
Common Stock38323.00.0
2026-04-01
2026-04-01
Sims Andrew John Hugh MacIntyreM · Exercise / conversion
Acquired
Common Stock29129.00.0
2026-04-01
2026-04-01
Sims Andrew John Hugh MacIntyreM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
29129.00.0
2026-04-01
2026-04-01
Sims Andrew John Hugh MacIntyreM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
38323.00.0
2026-04-01
2026-04-01
HEDRICK MARC HM · Exercise / conversion
Disposed
Common Stock201632.00.0
2026-04-01
2026-04-01
HEDRICK MARC HM · Exercise / conversion
Acquired
Common Stock159681.00.0
2026-04-01
2026-04-01
HEDRICK MARC HM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
201632.00.0
2026-04-01
2026-04-01
HEDRICK MARC HM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
159681.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001095981CERENOME, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Plus Therapeutics · alias · wikidata
  • Plus Therapeutics, Inc · alias · wikidata
  • PLUS THERAPEUTICS, INC. · former SEC name · 2019-02-08 to 2026-07-01
  • CYTORI THERAPEUTICS, INC. · former SEC name · 2005-05-26 to 2019-08-02
  • MACROPORE INC · former SEC name · 2001-07-16 to 2005-07-05
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$5.82M$6.20M
2023-12-31$4.91M$5.38M
2017-12-31$2.69M$3.66M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗